246 related articles for article (PubMed ID: 32165220)
1. Advances and challenges in nanocarriers and nanomedicines for veterinary application.
Carvalho SG; Araujo VHS; Dos Santos AM; Duarte JL; Silvestre ALP; Fonseca-Santos B; Villanova JCO; Gremião MPD; Chorilli M
Int J Pharm; 2020 Apr; 580():119214. PubMed ID: 32165220
[TBL] [Abstract][Full Text] [Related]
2. High drug-loading nanomedicines: progress, current status, and prospects.
Shen S; Wu Y; Liu Y; Wu D
Int J Nanomedicine; 2017; 12():4085-4109. PubMed ID: 28615938
[TBL] [Abstract][Full Text] [Related]
3. Phage-based delivery systems: engineering, applications, and challenges in nanomedicines.
Wang H; Yang Y; Xu Y; Chen Y; Zhang W; Liu T; Chen G; Wang K
J Nanobiotechnology; 2024 Jun; 22(1):365. PubMed ID: 38918839
[TBL] [Abstract][Full Text] [Related]
4. The development of nanocarriers for natural products.
Huang L; Luo S; Tong S; Lv Z; Wu J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1967. PubMed ID: 38757428
[TBL] [Abstract][Full Text] [Related]
5. Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine.
Elnaggar YS
Int J Nanomedicine; 2015; 10():3955-71. PubMed ID: 26109855
[TBL] [Abstract][Full Text] [Related]
6. Research progress on the nucleoside/nucleotide-loaded nanomedicines.
Zhou Z; Liu H; Ye M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):279-284. PubMed ID: 37476939
[TBL] [Abstract][Full Text] [Related]
7. Roadmap and strategy for overcoming infusion reactions to nanomedicines.
Szebeni J; Simberg D; González-Fernández Á; Barenholz Y; Dobrovolskaia MA
Nat Nanotechnol; 2018 Dec; 13(12):1100-1108. PubMed ID: 30348955
[TBL] [Abstract][Full Text] [Related]
8. Challenges and opportunities in the advancement of nanomedicines.
Wei A; Mehtala JG; Patri AK
J Control Release; 2012 Dec; 164(2):236-46. PubMed ID: 23064314
[TBL] [Abstract][Full Text] [Related]
9. State of the art in pediatric nanomedicines.
Abedin S; Adeleke OA
Drug Deliv Transl Res; 2024 Feb; ():. PubMed ID: 38324166
[TBL] [Abstract][Full Text] [Related]
10. Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence.
Alshawwa SZ; Kassem AA; Farid RM; Mostafa SK; Labib GS
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456717
[TBL] [Abstract][Full Text] [Related]
11. Physiological determinants and plausible '6R' roadmap for clinical success of nanomedicines.
Shahiwala A
Nanomedicine (Lond); 2023 Aug; 18(18):1207-1222. PubMed ID: 37650539
[TBL] [Abstract][Full Text] [Related]
12. An Overview of Polymeric Nanoplatforms to Deliver Veterinary Antimicrobials.
Zhou Y; Guo L; Dai G; Li B; Bai Y; Wang W; Chen S; Zhang J
Nanomaterials (Basel); 2024 Feb; 14(4):. PubMed ID: 38392714
[TBL] [Abstract][Full Text] [Related]
13. Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives.
Souto EB; Blanco-Llamero C; Krambeck K; Kiran NS; Yashaswini C; Postwala H; Severino P; Priefer R; Prajapati BG; Maheshwari R
Acta Biomater; 2024 May; 180():1-17. PubMed ID: 38604468
[TBL] [Abstract][Full Text] [Related]
14. Progress and challenges in the translation of cancer nanomedicines.
Tong F; Wang Y; Gao H
Curr Opin Biotechnol; 2024 Feb; 85():103045. PubMed ID: 38096768
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous Silica Nanoparticles as Theranostic Antitumoral Nanomedicines.
Baeza A; Vallet-Regí M
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33050613
[TBL] [Abstract][Full Text] [Related]
16. Current research trends of nanomedicines.
Liu Q; Zou J; Chen Z; He W; Wu W
Acta Pharm Sin B; 2023 Nov; 13(11):4391-4416. PubMed ID: 37969727
[TBL] [Abstract][Full Text] [Related]
17. Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review.
Maurya A; Singh AK; Mishra G; Kumari K; Rai A; Sharma B; Kulkarni GT; Awasthi R
Interv Med Appl Sci; 2019 Mar; 11(1):38-54. PubMed ID: 32148902
[TBL] [Abstract][Full Text] [Related]
18. Tackling the challenges of nanomedicines: are we ready?
Hertig JB; Shah VP; Flühmann B; Mühlebach S; Stemer G; Surugue J; Moss R; Di Francesco T
Am J Health Syst Pharm; 2021 Jun; 78(12):1047-1056. PubMed ID: 33599767
[TBL] [Abstract][Full Text] [Related]
19. Meeting Contemporary Challenges: Development of Nanomaterials for Veterinary Medicine.
Danchuk O; Levchenko A; da Silva Mesquita R; Danchuk V; Cengiz S; Cengiz M; Grafov A
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765294
[TBL] [Abstract][Full Text] [Related]
20. Green Nanotechnology-Driven Drug Delivery Assemblies.
Kanwar R; Rathee J; Salunke DB; Mehta SK
ACS Omega; 2019 May; 4(5):8804-8815. PubMed ID: 31459969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
